These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30267729)

  • 21. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
    Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
    Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapies negating neuroinflammation after brain trauma.
    Hellewell S; Semple BD; Morganti-Kossmann MC
    Brain Res; 2016 Jun; 1640(Pt A):36-56. PubMed ID: 26740405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment with ginseng total saponins improves the neurorestoration of rat after traumatic brain injury.
    Hu BY; Liu XJ; Qiang R; Jiang ZL; Xu LH; Wang GH; Li X; Peng B
    J Ethnopharmacol; 2014 Sep; 155(2):1243-55. PubMed ID: 25046825
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Environmental enrichment, alone or in combination with various pharmacotherapies, confers marked benefits after traumatic brain injury.
    de la Tremblaye PB; Cheng JP; Bondi CO; Kline AE
    Neuropharmacology; 2019 Feb; 145(Pt A):13-24. PubMed ID: 29499273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Traumatic brain injury and stem cell treatments: A review of recent 10 years clinical trials.
    Saboori M; Riazi A; Taji M; Yadegarfar G
    Clin Neurol Neurosurg; 2024 Apr; 239():108219. PubMed ID: 38471197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Neural Stem Cell Transplantation-Mediated Alteration of Microglial/Macrophage Phenotypes after Traumatic Brain Injury.
    Gao J; Grill RJ; Dunn TJ; Bedi S; Labastida JA; Hetz RA; Xue H; Thonhoff JR; DeWitt DS; Prough DS; Cox CS; Wu P
    Cell Transplant; 2016 Oct; 25(10):1863-1877. PubMed ID: 26980267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial specific therapeutic targets following brain injury.
    Yonutas HM; Vekaria HJ; Sullivan PG
    Brain Res; 2016 Jun; 1640(Pt A):77-93. PubMed ID: 26872596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
    Kumar A; Loane DJ
    Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigational agents for treatment of traumatic brain injury.
    Xiong Y; Zhang Y; Mahmood A; Chopp M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):743-60. PubMed ID: 25727893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology and treatment of cerebral edema in traumatic brain injury.
    Jha RM; Kochanek PM; Simard JM
    Neuropharmacology; 2019 Feb; 145(Pt B):230-246. PubMed ID: 30086289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential of mesenchymal stem cells alone, or in combination, to treat traumatic brain injury.
    Willing AE; Das M; Howell M; Mohapatra SS; Mohapatra S
    CNS Neurosci Ther; 2020 Jun; 26(6):616-627. PubMed ID: 32157822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt3a, a Protein Secreted by Mesenchymal Stem Cells Is Neuroprotective and Promotes Neurocognitive Recovery Following Traumatic Brain Injury.
    Zhao Y; Gibb SL; Zhao J; Moore AN; Hylin MJ; Menge T; Xue H; Baimukanova G; Potter D; Johnson EM; Holcomb JB; Cox CS; Dash PK; Pati S
    Stem Cells; 2016 May; 34(5):1263-72. PubMed ID: 26840479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catecholaminergic based therapies for functional recovery after TBI.
    Osier ND; Dixon CE
    Brain Res; 2016 Jun; 1640(Pt A):15-35. PubMed ID: 26711850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cells for therapy in TBI.
    Ahmed AI; Gajavelli S; Spurlock MS; Chieng LO; Bullock MR
    J R Army Med Corps; 2016 Apr; 162(2):98-102. PubMed ID: 26338987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stromal cell secretome as a therapeutic strategy for traumatic brain injury.
    Muhammad SA
    Biofactors; 2019 Nov; 45(6):880-891. PubMed ID: 31498511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic hypothermia and targeted temperature management in traumatic brain injury: Clinical challenges for successful translation.
    Dietrich WD; Bramlett HM
    Brain Res; 2016 Jun; 1640(Pt A):94-103. PubMed ID: 26746342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined bioscaffold with stem cells and exosomes can improve traumatic brain injury.
    Yuan J; Botchway BOA; Zhang Y; Wang X; Liu X
    Stem Cell Rev Rep; 2020 Apr; 16(2):323-334. PubMed ID: 31808037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats.
    Wali B; Sayeed I; Guthrie DB; Natchus MG; Turan N; Liotta DC; Stein DG
    Neuropharmacology; 2016 Oct; 109():148-158. PubMed ID: 27267687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Mesenchymal Stem Cells Act Multipotential in Traumatic Brain Injury?
    Dehghanian F; Soltani Z; Khaksari M
    J Mol Neurosci; 2020 May; 70(5):677-688. PubMed ID: 31897971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation of neural stem cells enhances expression of synaptic protein and promotes functional recovery in a rat model of traumatic brain injury.
    Ma H; Yu B; Kong L; Zhang Y; Shi Y
    Mol Med Rep; 2011; 4(5):849-56. PubMed ID: 21687946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.